COVID-19 outcomes in people living with HIV: Peering through the waves
- PMID: 37331214
- PMCID: PMC10209448
- DOI: 10.1016/j.clinsp.2023.100223
COVID-19 outcomes in people living with HIV: Peering through the waves
Abstract
Objective: To evaluate clinical characteristics and outcomes of COVID-19 patients infected with HIV, and to compare with a paired sample without HIV infection.
Methods: This is a substudy of a Brazilian multicentric cohort that comprised two periods (2020 and 2021). Data was obtained through the retrospective review of medical records. Primary outcomes were admission to the intensive care unit, invasive mechanical ventilation, and death. Patients with HIV and controls were matched for age, sex, number of comorbidities, and hospital of origin using the technique of propensity score matching (up to 4:1). They were compared using the Chi-Square or Fisher's Exact tests for categorical variables and the Wilcoxon for numerical variables.
Results: Throughout the study, 17,101 COVID-19 patients were hospitalized, and 130 (0.76%) of those were infected with HIV. The median age was 54 (IQR: 43.0;64.0) years in 2020 and 53 (IQR: 46.0;63.5) years in 2021, with a predominance of females in both periods. People Living with HIV (PLHIV) and their controls showed similar prevalence for admission to the ICU and invasive mechanical ventilation requirement in the two periods, with no significant differences. In 2020, in-hospital mortality was higher in the PLHIV compared to the controls (27.9% vs. 17.7%; p = 0.049), but there was no difference in mortality between groups in 2021 (25.0% vs. 25.1%; p > 0.999).
Conclusions: Our results reiterate that PLHIV were at higher risk of COVID-19 mortality in the early stages of the pandemic, however, this finding did not sustain in 2021, when the mortality rate is similar to the control group.
Keywords: COVID-19; HIV; Intensive care unit; Mechanical ventilation; Mortality.
Copyright © 2023 HCFMUSP. Published by Elsevier España, S.L.U. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflicts of interest.
Figures
Similar articles
-
Clinical characteristics and outcomes of people living with HIV hospitalized with COVID-19: a nationwide experience.Int J STD AIDS. 2021 Apr;32(5):435-443. doi: 10.1177/0956462420973106. Epub 2021 Feb 3. Int J STD AIDS. 2021. PMID: 33533294
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Admission diagnoses and outcomes among hospitalized people living with HIV during pre-COVID-19, COVID-19 and post-COVID-19 pandemic periods.Int J STD AIDS. 2025 Mar;36(3):231-240. doi: 10.1177/09564624241304849. Epub 2024 Dec 4. Int J STD AIDS. 2025. PMID: 39631405
-
Factors associated with SARS-CoV-2-related hospital outcomes among and between persons living with and without diagnosed HIV infection in New York State.PLoS One. 2022 May 25;17(5):e0268978. doi: 10.1371/journal.pone.0268978. eCollection 2022. PLoS One. 2022. PMID: 35613145 Free PMC article. Review.
-
HIV infection does not affect the risk of death of COVID-19 patients: A systematic review and meta-analysis of epidemiological studies.J Glob Health. 2022 Aug 17;12:05036. doi: 10.7189/jogh.12.05036. J Glob Health. 2022. PMID: 35972980 Free PMC article.
Cited by
-
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.Adv Ther. 2025 Feb;42(2):666-719. doi: 10.1007/s12325-024-03043-0. Epub 2024 Dec 16. Adv Ther. 2025. PMID: 39680311 Free PMC article. Review.
-
COVID-19 Breakthrough Infections Among People With HIV: A Statewide Cohort Analysis.J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):107-116. doi: 10.1097/QAI.0000000000003475. J Acquir Immune Defic Syndr. 2024. PMID: 39250644
-
Clinical outcomes and immunological response to SARS-CoV-2 infection among people living with HIV.Exp Biol Med (Maywood). 2024 Apr 2;249:10059. doi: 10.3389/ebm.2024.10059. eCollection 2024. Exp Biol Med (Maywood). 2024. PMID: 38628843 Free PMC article. Review.
References
-
- WHO - World Health Organization Consolidated guidelines on HIV prevention, testing, treatment, service delivery, and monitoring: recommendations for a public health approach. Geneva: World Health Organization; 2021 a. - PubMed
-
- Geretti AM, Stockdale AJ, Kelly SH, Cevik M, Collins S, Waters L, et al. Outcomes of coronavirus disease 2019 (COVID-19) related hospitalization among people with human immunodeficiency virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): a prospective observational study. Clin Infect Dis. 2021;73(7):e2095–e2106. - PMC - PubMed
-
- Hoffmann C, Casado JL, Härter G, Vizcarra P, Moreno A, Cattaneo D, et al. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Med. 2021;22(5):372–378. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical